263 related articles for article (PubMed ID: 15238561)
1. Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors.
Northrup NC; Roberts RE; Harrell TW; Allen KL; Howerth EW; Gieger TL
J Am Anim Hosp Assoc; 2004; 40(4):309-15. PubMed ID: 15238561
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy for incompletely resected canine mast cell tumors.
LaDue T; Price GS; Dodge R; Page RL; Thrall DE
Vet Radiol Ultrasound; 1998; 39(1):57-62. PubMed ID: 9491519
[TBL] [Abstract][Full Text] [Related]
4. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.
Weisse C; Shofer FS; Sorenmo K
J Am Anim Hosp Assoc; 2002; 38(1):71-3. PubMed ID: 11804319
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
6. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs.
Turrel JM; Kitchell BE; Miller LM; Théon A
J Am Vet Med Assoc; 1988 Oct; 193(8):936-40. PubMed ID: 3142828
[TBL] [Abstract][Full Text] [Related]
8. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
[TBL] [Abstract][Full Text] [Related]
10. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis.
Chaffin K; Thrall DE
Vet Radiol Ultrasound; 2002; 43(4):392-5. PubMed ID: 12175005
[TBL] [Abstract][Full Text] [Related]
11. Questions data supporting conclusions on grade-III mast cell tumors.
Schulman FY; Lipscomb TP
J Am Vet Med Assoc; 2004 Feb; 224(4):501; author reply 501. PubMed ID: 14989538
[No Abstract] [Full Text] [Related]
12. Reirradiation of tumors in cats and dogs.
Turrel JM; Théon AP
J Am Vet Med Assoc; 1988 Aug; 193(4):465-9. PubMed ID: 3139592
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993).
Frimberger AE; Moore AS; LaRue SM; Gliatto JM; Bengtson AE
J Am Anim Hosp Assoc; 1997; 33(4):320-4. PubMed ID: 9204467
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998).
Hahn KA; King GK; Carreras JK
J Am Vet Med Assoc; 2004 Jan; 224(1):79-82. PubMed ID: 14710881
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
Stanclift RM; Gilson SD
J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy for canine mast cell tumors.
Mayer MN
Can Vet J; 2006 Mar; 47(3):263-5. PubMed ID: 16604985
[No Abstract] [Full Text] [Related]
17. Nucleomorphometric analysis of canine cutaneous mast cell tumours.
Maiolino P; Cataldi M; Paciello O; Restucci B; De Vico G
J Comp Pathol; 2005; 133(2-3):209-11. PubMed ID: 16045919
[TBL] [Abstract][Full Text] [Related]
18. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs.
al-Sarraf R; Mauldin GN; Patnaik AK; Meleo KA
J Vet Intern Med; 1996; 10(6):376-8. PubMed ID: 8947870
[TBL] [Abstract][Full Text] [Related]
20. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
